Article Title (non-H1, visual presentation)
Complete Evaluation Process and Key Indicators Explained
In a reproductive center, a physical assessment is not a one-time checkup but a step-by-step decision-making process. At the overseas IVF clinic where I work, we divide the evaluation into three levels: Basic Fertility Screening → Organ Function & Genetic Assessment → Individualized Risk Stratification. Each level corresponds to different examination items and clinical decision points. The assessment results directly determine the IVF protocol, gonadotropin dosage, and whether third-party assistance is needed. Below, I will break down the evaluation logic and key indicators for each step based on our actual workflow.
==================== Actual Process (I) ====================1. The Actual Evaluation Process at Overseas IVF Clinics
Regardless of the patient's country of origin, our clinic's initial assessment follows a standardized pathway. The entire cycle typically takes 3 to 7 days (excluding waiting time for reports). The specific steps are as follows:
- Online Pre-screening & Medical Record Collection — Collect age, obstetric history, surgical history, chronic diseases, and medication records in advance. This step helps screen out cases clearly unsuitable for direct IVF, such as uncontrolled thyroid disease or endometrial pathology.
- Female Basic Fertility Examination — Blood tests for AMH, FSH, LH, E2, TSH, and PRL on menstrual cycle days 2-4, along with a transvaginal ultrasound to count antral follicles (AFC).
- Male Semen Analysis — Requires 2-7 days of abstinence. Includes routine semen analysis + sperm morphology + sperm DNA fragmentation index (DFI).
- Organ Function & Infection Screening — Includes uterine cavity assessment (ultrasound or hysteroscopy), thyroid function, coagulation profile, and screening for four infectious diseases (Hepatitis B, Hepatitis C, HIV, Syphilis).
- Genetic Screening — Chromosomal karyotype analysis (G-banding) for both partners, with optional carrier screening for conditions like thalassemia and spinal muscular atrophy when indicated.
- Individualized Risk Consultation — The attending physician discusses all reports face-to-face with the patient, covering: estimated number of oocytes retrieved, stimulation protocol options, PGT indications, expected success rate range, and risk warnings.
2. Core Examination Indicators and Clinical Interpretation
Among the assessment reports, 6 indicators are of primary concern to doctors. They directly determine ovarian reserve, egg quality, embryo potential, and transfer strategy.
| Indicator | Normal Reference Range | Clinical Significance | Notes |
|---|---|---|---|
| AMH | 1.0 – 4.0 ng/mL | Direct indicator of ovarian reserve; lower values indicate fewer remaining eggs. | Not affected by menstrual cycle; can be tested anytime. |
| FSH | 3.5 – 10.0 IU/L | Reflects ovarian function status; FSH > 12 suggests diminished reserve. | Must be tested on menstrual cycle days 2-4. |
| LH | 2.0 – 9.0 IU/L | Ratio to FSH > 2 raises suspicion of PCOS tendency. | Interpret in conjunction with FSH and AFC. |
| Antral Follicle Count (AFC) | Total 5 – 20 for both ovaries | Directly predicts response to ovarian stimulation; AFC < 5 indicates poor response. | Most accurate when measured by transvaginal ultrasound during menstruation. |
| Sperm Concentration | ≥ 15 million/mL | Values below this may necessitate ICSI or donor sperm. | Affected by abstinence period; results can vary significantly. |
| Sperm DNA Fragmentation Index (DFI) | ≤ 15% | DFI > 30% significantly reduces embryo implantation rates. | Associated with lifestyle, infections, and varicocele. |
Clinically, I often encounter patients who judge their "ability to do IVF" based solely on AMH and FSH. In reality, the combination of AMH + AFC + Age is the gold standard for predicting ovarian response. A normal AMH alone, but age over 40, still carries a high risk of oocyte aneuploidy, a point easily overlooked.
2.1 Chromosome and Genetic Testing
Chromosomal karyotype analysis is a "seemingly routine but far-reaching" item in the assessment. If either partner carries a balanced translocation, Robertsonian translocation, or mosaicism, it directly alters the strategy for embryo genetic testing. At our clinic, for patients with a history of recurrent miscarriage, pregnancy loss, or family genetic disorders, chromosomal testing is mandatory, not optional.
2.2 Uterine Cavity Evaluation
Hysteroscopy is not necessary for everyone, but it is required in the following situations: ultrasound suggests heterogeneous endometrium, suspected polyps or adhesions, history of uterine surgery, or recurrent implantation failure. Hysteroscopy allows direct visualization of the endometrial lining, color, and vascularity, making it the gold standard for assessing "soil" quality.
==================== Age-Specific Differences (D) ====================3. Differences in Assessment Focus by Age Group
Age is the most critical variable affecting the weight of assessment factors. The same indicator leads to completely different clinical decisions for a 30-year-old versus a 42-year-old patient. The table below shows the assessment priorities for different age groups:
| Age Group | Assessment Focus | Common Thresholds / Decision Points | Protocol Tendency |
|---|---|---|---|
| < 35 years | Basic fertility + Semen analysis + Infectious diseases | AMH > 1.5, AFC > 8, FSH < 10 | Conventional stimulation, primarily fresh embryo transfer. |
| 35 – 39 years | Basic indicators + Chromosomal karyotype + Genetic carrier screening | AMH > 1.0, AFC > 5, DFI < 20% | Consider PGT-A, increased proportion of frozen embryo transfers. |
| 40 – 42 years | Egg quality assessment + Uterine cavity + Metabolic screening | AMH > 0.5, AFC > 3, DFI < 15% | High-dose stimulation, mandatory PGT-A, may require egg donor consultation. |
| > 42 years | Comprehensive metabolic + Cardiovascular + Uterine cavity + Genetic counseling | AMH > 0.3, AFC ≥ 2, Endometrial thickness ≥ 7mm | Individualized mild stimulation, strongly recommend PGT-A, fully inform about egg donation options. |
Note: For women over 40, even if AMH is within the normal range, the rate of chromosomal aneuploidy in eggs can still exceed 60%. So, what do you need to prepare for overseas IVF at an advanced age? The most important thing is not "regulation" but a clear understanding and budget preparation for embryo genetic testing.
==================== Differences Between Countries (E) ====================4. Differences in Evaluation Systems Across Countries
Overseas IVF clinics have some structural differences in their evaluation standards, which can affect the choice of examinations and the order of the process. I have compared the evaluation characteristics of four major regions:
| Country / Region | Evaluation Characteristics | Typical Differences |
|---|---|---|
| United States | Very thorough genetic screening; carrier screening is routine. | Chromosomal karyotype + blastocyst genetic testing are almost standard. |
| Thailand | Streamlined process; can enter the cycle after basic evaluation. | High proportion of hysteroscopy assessments; tendency towards frozen embryo transfer. |
| Japan | Primarily mild stimulation protocols; assessment focuses on predicting poor ovarian response. | Stricter AMH thresholds used; more detailed AFC counting. |
| Europe (Spain/Greece) | Legal restrictions on embryo genetic testing are more common; assessment emphasis on maternal health. | More comprehensive metabolic, immune, and coagulation evaluations. |
When choosing a clinic in a different region, the assessment phase needs to be adjusted accordingly. For example, in the US, chromosomal karyotype and carrier screening are recommended to be completed before departure due to the long turnaround time for reports. In Thailand, some tests can be done locally, making the process more efficient. The answers to questions like when to do overseas IVF tests and how far in advance to prepare for overseas IVF are highly dependent on the destination.
==================== Doctor's Perspective (C) ====================5. Reproductive Specialist Perspective: Clinical Decision-Making Logic in Assessment
As a reproductive specialist, when I review assessment reports, I don't just look at whether individual indicators are "normal." Instead, I focus on the type of ovarian response and embryo potential indicated by the combination of indicators. Specifically:
- Poor Responder Type (AMH < 0.8, AFC < 5, FSH > 12) — Directly choose a mild stimulation or natural cycle protocol. Do not pursue a high number of oocytes; focus on egg quality.
- High Responder Type (AMH > 4.0, AFC > 20) — First choice is an antagonist protocol. Monitor OHSS risk throughout, and assess suitability for fresh embryo transfer.
- Normal Responder Type — Decide whether to add growth hormone or use a PPOS protocol based on age and medical history.
Additionally, male factors are often underestimated in the assessment. The scenario of normal sperm concentration but high DFI is not uncommon in clinical practice. When DFI > 30%, even if the female partner has good ovarian function, the embryo implantation rate will significantly decrease. Therefore, the list of male examinations for overseas IVF should not be limited to routine semen analysis; it must include DFI and sperm morphology.
6. Details Most Easily Overlooked in the Assessment
In clinical work, I have found that the following 4 details are often overlooked by patients, yet they directly impact the accuracy of the assessment results and the success rate of the cycle:
- AMH is not linked to the menstrual cycle, but using oral contraceptives within 2 weeks before the test can significantly suppress AMH levels. If a patient has recently used birth control pills or GnRH agonists, the AMH value may be artificially low, leading to an underestimation of ovarian reserve.
- Semen quality fluctuates widely. A single unsatisfactory semen analysis result should not lead to a definitive conclusion. A repeat test must be done after an interval of 2-4 weeks, with the abstinence period strictly controlled to 2-5 days.
- Chromosomal karyotype analysis takes 10-14 days for results. Many patients only do this test right before starting the cycle. If the result is abnormal, there may not be enough time to adjust the plan. It is recommended to order the chromosomal test as soon as you decide on overseas IVF.
- Passport validity requirements for overseas IVF are unrelated to the assessment itself, but an expired document can affect file creation and cycle initiation. Before the assessment, ensure your passport is valid for more than 6 months to avoid delays due to documentation issues.
Also, can you still do overseas IVF with low AMH? The answer is yes, but the focus of the assessment needs to shift: instead of pursuing a high number of oocytes, the goal is to maximize the quality of each egg through an individualized protocol. For individuals with low AMH, additional tests for Vitamin D and DHEA levels are needed, as these indicators are related to the follicular microenvironment.
==================== Frequently Asked Questions (Q) ====================7. Frequently Asked Questions
8. How Overseas IVF Clinics Assess Physical Condition: Summary of Core Dimensions
Combining all the above, overseas IVF clinics assess physical condition primarily across the following four dimensions:
| Dimension | Core Indicators | Assessment Purpose |
|---|---|---|
| Ovarian Reserve & Function | AMH, FSH, AFC, LH | Determine ovarian response type, choose stimulation protocol. |
| Sperm Quality & Genetics | Semen analysis, DFI, Chromosomal karyotype | Assess fertilization method, necessity of embryo genetic testing. |
| Uterine Cavity & Endocrine Environment | Hysteroscopy, Thyroid function, Coagulation profile | Confirm embryo implantation conditions, rule out miscarriage risks. |
| Overall Health & Risk Stratification | Age, BMI, Metabolic indicators, Cardiopulmonary function | Assess risks of pregnancy complications, establish safety thresholds. |
These four dimensions are indispensable. A deficiency in any one dimension requires targeted adjustments in the protocol. For example, if the uterine cavity environment is problematic, surgery must be done before starting the cycle; if DFI is too high, antioxidant therapy is needed first. The purpose of the assessment is not to "judge whether it's possible," but to "determine how to maximize success rates and minimize risks."
==================== Closing: Doctor's Advice ==================== Bottom spacing
Comments (0)